Isabelle Soerjomataram

Isabelle Soerjomataram

Top Cited Scholar 2023
Auto-generated profile, based on publicly available information

Isabelle Soerjomataram

Cancer Surveillance Branch International Agency for Research on Cancer Lyon France

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in European Journal of Cancer
Verified
Journal Article
Closed access
JFJ. Ferlay
J. Ferlay
MCM. Colombet
M. Colombet
ISI. Soerjomataram
I. Soerjomataram
TDT. Dyba
T. Dyba
GRG. Randi
G. Randi
FBF. Bray
F. Bray

2 June 2021 in Nature Reviews Clinical Oncology
Verified
Journal Article
Closed access
PDF file
ISIsabelle Soerjomataram
Isabelle Soerjomataram
FBFreddie Bray
Freddie Bray

8 July 2026 in CA: A Cancer Journal for Clinicians
Verified
Journal Article
Open access
PDF file
HSHyuna Sung
Hyuna Sung
AFAdalberto M. Filho
Adalberto M. Filho
MLMathieu Laversanne
Mathieu Laversanne
JFJacques Ferlay
Jacques Ferlay
RSRebecca L. Siegel
Rebecca L. Siegel
FBFreddie Bray
Freddie Bray
This article provides updated global cancer statistics for the year 2024 based on the GLOBOCAN estimates of the International Agency for Research on Cancer. The authors describe national cancer incidence and mortality by world region and the Human Development Index and predict the burden in 2050 based on demographic trends. In 2024, an estimated 20.6 million new cancer cases (19.5 million excluding nonmelanoma skin cancer) and 9.8 million deaths (9.7 million excluding nonmelanoma skin cancer) occurred worldwide, equivalent to one in five people developing cancer during their lifetime and one in nine men and one in 13 women dying from the disease. Lung cancer is the most frequently diagnosed cancer, responsible for almost 2.6 million new cases (12.8%), followed by female breast (11.8%), colorectal (9.9%), prostate (7.5%), and stomach (4.7%) cancer. Lung cancer is also the leading cause of cancer death, with an estimated 1.9 million deaths (19.1%), followed by colorectal (9.4%), liver (7.5%), female breast (7.1%), and stomach (6.6%) cancer. Incidence rates vary four‐ to five‐fold across regions, with the highest rates found in Australia/New Zealand (men, 477 per 100,000; women, 396 per 100,000), whereas mortality rates differ two‐fold, with elevated rates in Eastern Europe for men (158 per 100,000) and Melanesia for women (108 per 100,000). The incidence burden is predicted to reach 34.4 million by 2050, up 67% from 2024, with the largest proportional increases in lower Human Development Index countries. Although global variation in cancer profiles demands a nuanced approach to cancer control at national and regional levels, primary prevention must be at the forefront, including intensified efforts to reduce tobacco use, prevent infections, lower alcohol consumption and excess body weight, and increase physical activity.

1 November 2012 in The Lancet
Verified
Journal Article
Closed access
ISIsabelle Soerjomataram
Isabelle Soerjomataram
JLJoannie Lortet-Tieulent
Joannie Lortet-Tieulent
DPD Maxwell Parkin
D Maxwell Parkin
JFJacques Ferlay
Jacques Ferlay
CMColin Mathers
Colin Mathers
FBFreddie Bray
Freddie Bray

11 September 2021 in Nutrients
Verified
Journal Article
Open access
PDF file
HRHarriet Rumgay
Harriet Rumgay
NMNeil Murphy
Neil Murphy
PFPietro Ferrari
Pietro Ferrari
ISIsabelle Soerjomataram
Isabelle Soerjomataram
Approximately 4% of cancers worldwide are caused by alcohol consumption. Drinking alcohol increases the risk of several cancer types, including cancers of the upper aerodigestive tract, liver, colorectum, and breast. In this review, we summarise the epidemiological evidence on alcohol and cancer risk and the mechanistic evidence of alcohol-mediated carcinogenesis. There are several mechanistic pathways by which the consumption of alcohol, as ethanol, is known to cause cancer, though some are still not fully understood. Ethanol’s metabolite acetaldehyde can cause DNA damage and block DNA synthesis and repair, whilst both ethanol and acetaldehyde can disrupt DNA methylation. Ethanol can also induce inflammation and oxidative stress leading to lipid peroxidation and further DNA damage. One-carbon metabolism and folate levels are also impaired by ethanol. Other known mechanisms are discussed. Further understanding of the carcinogenic properties of alcohol and its metabolites will inform future research, but there is already a need for comprehensive alcohol control and cancer prevention strategies to reduce the burden of cancer attributable to alcohol.

30 March 2022 in International Journal of Cancer
Verified
Journal Article
Closed access
CCCitadel J. Cabasag
Citadel J. Cabasag
PFPaula J. Fagan
Paula J. Fagan
JFJacques Ferlay
Jacques Ferlay
JVJerome Vignat
Jerome Vignat
MLMathieu Laversanne
Mathieu Laversanne
ISIsabelle Soerjomataram
Isabelle Soerjomataram